Evidence map›Paper›PMID 41644583›Full record

ArticleScientific reports2026

Proteomic atlas of human peritoneal tissue.

Qiangmin Zhang, Christopher Sherry, Xi Peng, Yunxiang Fu, Nujsaubnusi Vue, Rosie Blodgett, Hyun Young Park, Erin E Grayhack, Neda Dadgar, Xue Li and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Qiangmin ZhangAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Christopher SherryAllegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Xi PengAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Yunxiang FuAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Nujsaubnusi VueAllegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Rosie BlodgettAllegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Hyun Young ParkAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Erin E GrayhackAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Neda DadgarAllegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Xue LiAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Ali H ZaidiAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Vera DonnenbergDepartment of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
David L BartlettAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Albert DonnenbergAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA.
Kunhong XiaoAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA. Kunhongkevin.Xiao@ahn.org.
Patrick L WagnerAllegheny Health Network Research Institute, Allegheny Health Network, Pittsburgh, PA, 15212, USA. Patrick.Wagner@ahn.org.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
NCI NIH HHS P30 CA047904PA State Health Research Formula Grant 4100095527
6 · The paper itself

Abstract

Peritoneal carcinomatosis occurs when the parietal and visceral peritoneum are involved with multifocal metastatic tumors, most commonly arising from abdominopelvic organ sites. The prevailing model of peritoneal carcinomatosis sees the peritoneal lining as the ‘soil’ onto which metastatic cancer cells attach and grow. Molecular methods to assess the functional status of this microenvironment have not been well developed. To address this gap, we analyzed the protein composition of peritoneal tissue using liquid chromatography-tandem mass spectrometry on both fresh frozen and formalin-fixed, paraffin-embedded benign tissue (FFPE) samples, employing an ultra-high-resolution timsTOF mass spectrometer. The protein yield in peritoneal tissue was lower than that observed from similar studies of other visceral organ tissues. Extracellular matrix (ECM) proteins were present in high abundance and may be contributory to cancer cell attachment and invasion in peritoneal carcinomatosis. We further quantified key signal transduction and metabolic proteins known to contribute to cancer progression, along with defined tumor suppressors and oncoproteins. Our findings represent a baseline catalog of the proteomic composition of the peritoneal lining, as a comparison dataset for future studies focused on alterations in pathologic states such as peritoneal carcinomatosis.

Indexed as

Peritoneal NeoplasmsPeritoneumProteomeProteomicsChromatography, LiquidExtracellular Matrix ProteinsFemaleHumansTandem Mass SpectrometryExtracellular Matrix ProteinsProteomeLC-MS/MSPeritoneal carcinomatosisPeritoneal tissueProteomics

Identifiers

PMID41644583
PMCPMC12923890

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.